Regularly advising on high-value deals, Jonathan Farrokhnia of Bell Nunnally & Martin LLP provides strong counsel to his clients on all corporate governance matters, focusing particularly on M&A. His previous experience includes advising family businesses on their sales to strategic buyers and advising private equity firms on roll-up acquisitions. A recent example is his work on the multi-million-dollar sale of Texas-based virtual preventative care provider Catapult Health to a multinational healthcare company.
Legal 500 Editorial commentary

Accolades

Dallas Elite

Profile

Position

Partner

Career

Jonathan helps guide clients worldwide through intricate legal matters and high-value deals. His analytical and detail-oriented approach ensures efficient navigation of even the most complex transactions and compliance issues.
Jonathan Farrokhnia’s practical style and deep understanding of business dynamics enables him to deliver actionable advice and effective solutions that align with clients’ business goals. His practice focuses on mergers and acquisitions, equity and debt financings, securities law compliance, corporate governance and other transactional matters. He frequently represents private equity firms in the purchase and sale of portfolio companies, developers, purchasers and sellers of renewable energy projects, venture capital firms and early-stage issuers, public and private companies in securities offerings, and public companies in securities law compliance and corporate governance issues.

Memberships

  • State Bar of Texas
    • Member
  • State Bar of Texas
    • Business Law Section Mergers and Acquisitions Committee

Education

Education

  • JD, Duke University School of Law, 2013
  • BSM, summa cum laude, Tulane University, 2010

Admissions

  • Texas

Content supplied by Bell Nunnally & Martin LLP

Key clients

  • Catapult Health
  • VisionPoint
  • Crux Capital
  • Skyline Cabinetry
  • BASE Capital
  • Frontier Direct Care

Work highlights

Represented Catapult Health in its sale to a publicly traded multinational telemedicine and virtual healthcare company.
Represented VisionPoint in its merger-of-equals with Navitas.